ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Position in MNKD — Mannkind Corp

CIK 1164508 BOSTON, MA

Position in MNKD

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,359,221

-$344,636 QoQ

Shares Held

319,066

+6.2% QoQ

Ownership

0.099%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#54

of 254 holders

Holding Since

Dec 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $2,519,535,758 across 72 Biotechnology names. MNKD ranks #55 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	738,378	$366,774,503
2	INCY	Incyte Corp	2,744,958	$311,168,438
3	REGN	Regeneron Pharmaceuticals, Inc.	393,685	$245,478,344
4	EXEL	Exelixis, Inc.	4,365,926	$237,550,033
5	GMAB	Genmab A/S	4,975,324	$136,672,150
6	RPRX	Royalty Pharma plc	2,435,341	$136,549,569
7	HALO	Halozyme Therapeutics, Inc.	1,704,623	$133,420,842
8	ONC	BeOne Medicines Ltd.	249,758	$71,173,537

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,359,221	319,066	+6.2%	Shares	Defined	2026-08-13
2025-12-31	$1,703,857	300,504	-72.7%	Shares	Defined	2026-02-13
2025-06-30	$4,111,108	1,099,227	-59.5%	Shares	Defined	2025-08-13
2025-03-31	$13,663,637	2,716,429	-44.4%	Shares	Defined	2025-05-14
2024-12-31	$31,427,325	4,887,609	+275.9%	Shares	Defined	2025-02-12
2024-09-30	$8,177,786	1,300,125	+185.0%	Shares	Defined	2024-11-14
2024-03-31	$2,066,730	456,232	-21.1%	Shares	Defined	2024-05-15
2023-09-30	$2,387,573	578,105	+384.6%	Shares	Defined	2023-11-14
2020-12-31	$373,409	119,300	—	Shares	Defined	2021-02-12
No filing history on record for this holder in this stock.